Le Lézard
Classified in: Health
Subjects: PER, LBR, POL

Express Scripts Appoints James M. Havel Chief Financial Officer


ST. LOUIS, Oct. 24, 2017 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that James M. Havel, who previously served as Express Scripts' Executive Vice President, has been named Executive Vice President and Chief Financial Officer, effective October 25, 2017. Eric Slusser, Executive Vice President and Chief Financial Officer, is leaving the Company to pursue other opportunities, but will stay with the Company through the first quarter of 2018 in order to ensure a smooth transition.

Express Scripts, St. Louis, Missouri. (PRNewsfoto/Express Scripts)

"We are pleased to have a professional with Jim Havel's financial and operational expertise, as well as proven experience with Express Scripts, to lead our finance function and manage a seamless transition," said Tim Wentworth, Chief Executive Officer and President of Express Scripts. "Given our Enterprise Value Initiative, the eviCore transaction and the dynamic nature of our industry, we are fortunate to have someone in the CFO position who understands our business and can make an immediate contribution.  Jim is that person."

Wentworth thanked Slusser for his leadership and his contributions to the company's success. "Eric has been a strong steward of our shareholders' financial resources and played an integral role in developing our Enterprise Value Initiative and the eviCore transaction," he added. "More importantly, Eric built out a strong finance team that has laid a solid foundation for our long-term success."

Havel joined Express Scripts in January 2015 and served as the Company's Interim Chief Financial Officer until September 2015. Before joining Express Scripts, Havel served as Chief Financial Officer of Major Brands Holdings, a privately-held beverage distribution company. He also spent more than 34 years with Ernst & Young LLP, where he began his career in 1976. During his time with Ernst & Young LLP, Havel served as an audit partner and in a number of firm leadership roles, including as managing partner of two different offices. Havel is a member of the board of directors of Enterprise Financial Services Corp. and is a Certified Public Accountant.

About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

Investor Contact
Ben Bier
314-810-3115
[email protected]

Media Contacts
Phil Blando
314-684-6514
[email protected]

Jennifer Luddy
201-269-6402
[email protected]

 

SOURCE Express Scripts


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: